BBWI

Bath & Body Works Inc. (BBWI) | Rumor.io

Bath & Body Works

BBWI

Attention (50-day avg)0%

Attention rank (50-day avg)#917

Bullish sentiment (50-day avg)93%

Price to earnings ratio4.32

Market capitalization3.3B

Earnings per share3.81

Dividend yield (TTM)4.94%

Revenue (annual)7.3B

Net income (annual)649M

Social

What share of all stock conversation is about BBWI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% 0	0% 0

Aug 26

Bath & Body Works reports Q2 earnings with revenue of $1.51B, down 2.3% YoY, and adjusted EPS of $0.62, exceeding estimates by $0.38.
The company raises FY26 EPS guidance to $3.13-$3.33 and narrows its sales-decline outlook to 2.5%-4%, despite Q2 sales falling 2.3%.
Despite the earnings beat, Bath & Body Works' stock price falls 3.3% premarket, with some analysts questioning the valuation and the company's growth outlook.

Generated by AI

Sentiment

Of the messages about BBWI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	50% -37.5	98.86% +11.41	64.63% -9.62
Bearish	0%	50% +37.5	1.14% -11.41	35.37% +9.62

Bullish· Aug 26

The company reported a Q2 earnings beat, with adjusted earnings per share reaching $0.62, exceeding estimates by $0.38.
Despite concerns over declining year-over-year revenue, the stock's solid gross margins and healthy cash flow support a 4.55% dividend yield, making it a potential value trap.
The company's raised FY26 EPS guidance to $2.60-$2.80, with narrowed net sales guidance to a decline between 4% and 2.5% for the year, suggesting a potential turnaround in the early stages.

Bearish· Nov 21

$BBWI's new CEO has been met with a massive no-confidence vote, with analysts and investors expressing disappointment with the company's strategy and guidance.
Morgan Stanley downgraded $BBWI to Equalweight and slashed its price target to $18, citing an elongated turnaround path and potential growth/margin expansion challenges.
$BBWI's recent earnings miss and guidance cut have led to a significant sell-off, with some analysts and investors questioning the company's ability to forecast its business and its CEO's leadership.

Generated by AI

Topics

Of the messages about BBWI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	85.71%	19.39%
Earnings	—	0%	0%	15.31%
Macro	—	0%	14.29%	32.43%
Analysts	—	0%	0%	30.85%
Technical Analysis	—	0%	0%	1.82%
Controversies	—	0%	0%	0.2%

Earnings· Aug 26

Bath & Body Works ($BBWI) reported Q2 earnings, with adjusted EPS of $0.62, beating estimates by 158.33% and exceeding the previous year's EPS by 67.57%.
The company's net sales of $1.514B beat estimates by 1.15% and showed a 2.26% year-over-year decline, but direct net sales growth was achieved for the first time since 2021.
Bath & Body Works raised its FY26 EPS guidance to $3.13-$3.33 and narrowed its sales-decline outlook to 2.5%-4%, despite Q2 sales falling 2.3% to $1.51B.

Analysts· Nov 21

Analysts at multiple firms, including Morgan Stanley, Goldman Sachs, and Robert W. Baird, have downgraded Bath & Body Works (BBWI) to Equal-Weight or Neutral, with price targets ranging from $17 to $19.
Wells Fargo analyst Ike Boruchow maintains an Overweight rating on BBWI with a price target of $25, while B of A Securities has a Buy rating with a target of $26.
The downgrades are due to concerns over an elongated turnaround path for the company, with some analysts seeing growth and margin expansion as potentially out of reach.

Announcements· May 18

$BBWI stock surged by 9.8% after Bath & Body Works reported stronger-than-expected earnings and revenue for Q1, with EPS beating expectations by $0.07.
The company raised its full-year earnings guidance and reported Q1 net sales of $1.396 billion, a decrease of $54 million compared to the same period in the previous year.
Bath & Body Works updated its 2023 forecast, expecting flat net sales to a mid-single digit decline compared to the previous year, with EPS expected to be between $2.70 and $3.10.

Controversies· Jun 5

A social media post compares Elon Musk's actions during the 2020 lockdown to a hypothetical individual who made a bullish DD on BBWI and sold calls, suggesting both got away with breaking lockdown regulations.
The post implies that if a non-celebrity had broken lockdown rules, they would have faced fines and possibly handcuffs, highlighting a perceived double standard.
The comparison is made in the context of a broader discussion about how Musk was able to reopen his facility during the lockdown without consequences.

Macro· Nov 13

* Bath & Body Works is expected to report earnings this week, with investors looking for guidance on the company's performance.
* The company's quarterly earnings release may have a significant impact on the stock market, particularly if it deviates from analyst expectations.
* A potential government shutdown and subsequent economic impact could also affect Bath & Body Works' stock price, making it a macro-relevant topic for investors.

Technical Analysis· Dec 6

BBWI has a bullish scenario with potential resistance at 44.86, 46.13, and 47.18, and a possible run to 51.25 if it breaks through these levels.
The bearish scenario for BBWI involves a potential drop to the 34-28 range if it rejects 44.86 and breaks 42.27.
A short signal for BBWI is being awaited based on 18-24 trades on the 30-min chart, with a free trial available to view the chart.

Generated by AI

Community

Of the messages about BBWI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	20%	33.33%	81.18%	35.36%
Newcomers	80%	66.67%	18.82%	64.64%

Regulars· Aug 26

Bath & Body Works reported Q2 earnings of $0.58 per share, beating estimates by 158.33% and YoY growth of 67.57%.
The company's net sales fell 2.3% YoY to $1.514B, with direct and international sales growing despite overall soft sales.
Bath & Body Works raised full-year guidance, with adjusted EPS expected to be $2.60-$2.80 and FY26 net sales expected to be -4% to -2.5%.

Newcomers· Aug 26

The asset's recent Q2 earnings beat expectations, with net income jumping 84% to $118M, and the company raised its FY26 EPS guidance to $3.13-$3.33.
The company's valuation is considered cheap, with a 5x earnings multiple, a 4% dividend yield, and solid free cash flow generation, making it an interesting buy at current levels.
The asset's strong earnings and guidance raise have led to a price increase, with the stock up $0.66 intraday, and potential upside targets at $18.70 and $19.40.

Generated by AI

Bath & Body Works (BBWI) just rolled out Essentials, a sensitive-skin-focused body care line with hypoallergenic formulas and soft fragrances, giving investors fresh data on how the retailer is expanding within its core categories. Recent trading tells a different story than the product buzz. Bath & Body Works shares have fallen about 30% over the past 90 days and the 1-year total shareholder return is down roughly 35%, signalling fading momentum, even as Essentials and holiday launches aim...

18h agofinance.yahoo.com

Analysts Offer Insights on Consumer Cyclical Companies: Bath & Body Works (BBWI) and On Holding AG (ONON)

Detailed price information for On Holding Ag Cl A (ONON-N) from The Globe and Mail including charting and trades.

23h agoThe Globe and Mail

Bath & Body Works launches sensitive skin line with an eye on $100B market (BBWI:NYSE)

1d agoSeeking Alpha

Bath & Body Works Introduces Essentials, a New Body Care Franchise Made for Sensitive Skin

Bath & Body Works Essentials Bath & Body Works is launching Essentials, a new body care franchise Dr. Michelle Henry Bath & Body Works is partnering with board-certified dermatologist Dr. Michelle Henry to help consumers better understand the ingredients in Essentials What You Should Know: Bath & Body Works is launching Essentials, a new body care franchise made for sensitive skin, available in stores and online in the U.S. and Canada on Sept. 28 and more international markets next year.Every pr

1d agoYahoo Finance

Bath & Body Works (BBWI) Down 9.9% Since Last Earnings Report: Can It Rebound?

Bath & Body Works (BBWI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

4d agoYahoo Finance

Barington Capital takes Bath & Body Works stake, pushes for sale, Bloomberg reports

19d agoReuters

Also Discussed

Investors talking about BBWI also mention

#	Name	Attention
1	Victoria's Secret & Co.VSXY	0%0
2	Abercrombie & Fitch Co. Class A Common StockANF	0%-0.01
3	PMNT - Perfect Moment Ltd. Common Stock	——
4	Dillard's Inc.DDS	0%0
5	Kontoor Brands Inc.KTB	0%0
6	Greif Inc. Class A Common StockGEF	0%0
7	Lyell Immunopharma, Inc.LYEL	0.01%new
8	IHS Holding Ltd.IHS	0%0
9	Installed Building Products, Inc.IBP	0%0
10	Melco Resorts & Entertainment Ltd. ADRMLCO	0%0

Bath & Body Works Inc.

Consumer Cyclical
Specialty Retail

Bath & Body Works Inc. is a specialty retailer focused on personal care, body care, and home fragrance products. Bath & Body Works offers a broad assortment of items including fine fragrance mists, body lotions, body creams, body wash, hand soaps, sanitizers, 3-wick candles, and home fragrance diffusers. The company sells through company-operated stores and e-commerce channels in the United States and Canada, while also reaching international customers through franchise, license, and wholesale partnerships. Its product mix is built around fragranced collections and seasonal assortments designed for everyday use across home and personal care routines. Bath & Body Works Inc. operates as a recognized consumer brand in the specialty retail market, with a business model centered on private-label merchandise, repeat purchasing, and omnichannel distribution.

Website

Location

Three Limited Parkway

Columbus, OH, 43230

United States

Social

What share of all stock conversation is about BBWI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% 0	0% 0

Aug 26

Bath & Body Works reports Q2 earnings with revenue of $1.51B, down 2.3% YoY, and adjusted EPS of $0.62, exceeding estimates by $0.38.
The company raises FY26 EPS guidance to $3.13-$3.33 and narrows its sales-decline outlook to 2.5%-4%, despite Q2 sales falling 2.3%.
Despite the earnings beat, Bath & Body Works' stock price falls 3.3% premarket, with some analysts questioning the valuation and the company's growth outlook.

Generated by AI

Sentiment

Of the messages about BBWI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	50% -37.5	98.86% +11.41	64.63% -9.62
Bearish	0%	50% +37.5	1.14% -11.41	35.37% +9.62

Bullish· Aug 26

The company reported a Q2 earnings beat, with adjusted earnings per share reaching $0.62, exceeding estimates by $0.38.
Despite concerns over declining year-over-year revenue, the stock's solid gross margins and healthy cash flow support a 4.55% dividend yield, making it a potential value trap.
The company's raised FY26 EPS guidance to $2.60-$2.80, with narrowed net sales guidance to a decline between 4% and 2.5% for the year, suggesting a potential turnaround in the early stages.

Bearish· Nov 21

$BBWI's new CEO has been met with a massive no-confidence vote, with analysts and investors expressing disappointment with the company's strategy and guidance.
Morgan Stanley downgraded $BBWI to Equalweight and slashed its price target to $18, citing an elongated turnaround path and potential growth/margin expansion challenges.
$BBWI's recent earnings miss and guidance cut have led to a significant sell-off, with some analysts and investors questioning the company's ability to forecast its business and its CEO's leadership.

Generated by AI

Topics

Of the messages about BBWI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	85.71%	19.39%
Earnings	—	0%	0%	15.31%
Macro	—	0%	14.29%	32.43%
Analysts	—	0%	0%	30.85%
Technical Analysis	—	0%	0%	1.82%
Controversies	—	0%	0%	0.2%

Earnings· Aug 26

Bath & Body Works ($BBWI) reported Q2 earnings, with adjusted EPS of $0.62, beating estimates by 158.33% and exceeding the previous year's EPS by 67.57%.
The company's net sales of $1.514B beat estimates by 1.15% and showed a 2.26% year-over-year decline, but direct net sales growth was achieved for the first time since 2021.
Bath & Body Works raised its FY26 EPS guidance to $3.13-$3.33 and narrowed its sales-decline outlook to 2.5%-4%, despite Q2 sales falling 2.3% to $1.51B.

Analysts· Nov 21

Analysts at multiple firms, including Morgan Stanley, Goldman Sachs, and Robert W. Baird, have downgraded Bath & Body Works (BBWI) to Equal-Weight or Neutral, with price targets ranging from $17 to $19.
Wells Fargo analyst Ike Boruchow maintains an Overweight rating on BBWI with a price target of $25, while B of A Securities has a Buy rating with a target of $26.
The downgrades are due to concerns over an elongated turnaround path for the company, with some analysts seeing growth and margin expansion as potentially out of reach.

Announcements· May 18

$BBWI stock surged by 9.8% after Bath & Body Works reported stronger-than-expected earnings and revenue for Q1, with EPS beating expectations by $0.07.
The company raised its full-year earnings guidance and reported Q1 net sales of $1.396 billion, a decrease of $54 million compared to the same period in the previous year.
Bath & Body Works updated its 2023 forecast, expecting flat net sales to a mid-single digit decline compared to the previous year, with EPS expected to be between $2.70 and $3.10.

Controversies· Jun 5

A social media post compares Elon Musk's actions during the 2020 lockdown to a hypothetical individual who made a bullish DD on BBWI and sold calls, suggesting both got away with breaking lockdown regulations.
The post implies that if a non-celebrity had broken lockdown rules, they would have faced fines and possibly handcuffs, highlighting a perceived double standard.
The comparison is made in the context of a broader discussion about how Musk was able to reopen his facility during the lockdown without consequences.

Macro· Nov 13

* Bath & Body Works is expected to report earnings this week, with investors looking for guidance on the company's performance.
* The company's quarterly earnings release may have a significant impact on the stock market, particularly if it deviates from analyst expectations.
* A potential government shutdown and subsequent economic impact could also affect Bath & Body Works' stock price, making it a macro-relevant topic for investors.

Technical Analysis· Dec 6

BBWI has a bullish scenario with potential resistance at 44.86, 46.13, and 47.18, and a possible run to 51.25 if it breaks through these levels.
The bearish scenario for BBWI involves a potential drop to the 34-28 range if it rejects 44.86 and breaks 42.27.
A short signal for BBWI is being awaited based on 18-24 trades on the 30-min chart, with a free trial available to view the chart.

Generated by AI

Community

Of the messages about BBWI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	20%	33.33%	81.18%	35.36%
Newcomers	80%	66.67%	18.82%	64.64%

Regulars· Aug 26

Bath & Body Works reported Q2 earnings of $0.58 per share, beating estimates by 158.33% and YoY growth of 67.57%.
The company's net sales fell 2.3% YoY to $1.514B, with direct and international sales growing despite overall soft sales.
Bath & Body Works raised full-year guidance, with adjusted EPS expected to be $2.60-$2.80 and FY26 net sales expected to be -4% to -2.5%.

Newcomers· Aug 26

The asset's recent Q2 earnings beat expectations, with net income jumping 84% to $118M, and the company raised its FY26 EPS guidance to $3.13-$3.33.
The company's valuation is considered cheap, with a 5x earnings multiple, a 4% dividend yield, and solid free cash flow generation, making it an interesting buy at current levels.
The asset's strong earnings and guidance raise have led to a price increase, with the stock up $0.66 intraday, and potential upside targets at $18.70 and $19.40.

Generated by AI

Bath & Body Works

Social

Aug 26

Bullish· Aug 26

Bearish· Nov 21

Earnings· Aug 26

Analysts· Nov 21

Announcements· May 18

Controversies· Jun 5

Macro· Nov 13

Technical Analysis· Dec 6

Regulars· Aug 26

Newcomers· Aug 26

Is Bath & Body Works (BBWI) Cheap As Essentials Launches And Shares Slide?

Analysts Offer Insights on Consumer Cyclical Companies: Bath & Body Works (BBWI) and On Holding AG (ONON)

Bath & Body Works launches sensitive skin line with an eye on $100B market (BBWI:NYSE)

Bath & Body Works Introduces Essentials, a New Body Care Franchise Made for Sensitive Skin

Bath & Body Works (BBWI) Down 9.9% Since Last Earnings Report: Can It Rebound?

Barington Capital takes Bath & Body Works stake, pushes for sale, Bloomberg reports

Also Discussed

Bath & Body Works Inc.

Company Information

Location

Is Bath & Body Works (BBWI) Cheap As Essentials Launches And Shares Slide?

Analysts Offer Insights on Consumer Cyclical Companies: Bath & Body Works (BBWI) and On Holding AG (ONON)

Bath & Body Works launches sensitive skin line with an eye on $100B market (BBWI:NYSE)

Bath & Body Works Introduces Essentials, a New Body Care Franchise Made for Sensitive Skin

Bath & Body Works (BBWI) Down 9.9% Since Last Earnings Report: Can It Rebound?

Barington Capital takes Bath & Body Works stake, pushes for sale, Bloomberg reports

Also Discussed

Social

Aug 26

Bullish· Aug 26

Bearish· Nov 21

Earnings· Aug 26

Analysts· Nov 21

Announcements· May 18

Controversies· Jun 5

Macro· Nov 13

Technical Analysis· Dec 6

Regulars· Aug 26

Newcomers· Aug 26